Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Systemic lupus erythematosus (SLE) is associated with a significantly elevated risk of cardiovascular disease (CVD).
• While atherosclerosis contributes, SLE-related CVD involves multiple complex pathophysiologic mechanisms beyond traditional risk factors.
• These mechanisms include thrombotic events and ongoing inflammation.

Purpose of the Study:

• To review current knowledge on risk factors and mechanisms for atherosclerosis and clinical CVD in SLE.
• To highlight the importance of lupus-specific factors in CVD development.
• To discuss the impact of varying CVD definitions and outcomes in research.

Main Methods:

• Literature review summarizing existing research on CVD risk factors in SLE.
• Analysis of pathophysiologic mechanisms contributing to vascular events in SLE patients.
• Discussion of traditional versus lupus-related risk factors.

Main Results:

• Both traditional CVD risk factors and SLE-specific factors (endothelial dysfunction, inflammation, renal impairment, disease activity, autoantibodies, genetics) are critical.
• Lupus-related factors may be equally or more important than traditional factors.
• Combined or separate contributions of risk factors increase atherosclerosis and clinical CVD risk.

Conclusions:

• CVD in SLE is multifactorial, involving atherosclerosis, thrombosis, and inflammation.
• Lupus-specific factors play a paramount role in CVD pathogenesis.
• Standardized definitions and outcomes are needed for clearer research comparisons in SLE CVD studies.